Daily non-political popular news in brief.

Researchers identify new therapy for patients with Crohn's disease

A study led by Mayo Clinic found that adalimumab ((HUMIRA) is an effective treatment for adults with Crohn's disease who do not respond to infliximab (REMICADE)) therapy. These findings were published online today by Annals of Internal Medicine.

Read more »

Keywords: researchers, identify, therapy, patients, crohn, disease, researcher, patient

« Previous | Next »

Similar news on "Researchers identify new therapy for patients with Crohn's disease":

1. Research shows new therapy is effective for patients with Crohn's disease
   07-18-2007 · EurekAlert!
   Mayo Clinic researchers have found that Certolizumab pegol is an effective treatment for adults with Crohn's disease, according to two new studies. These findings were published in today's issue of the New England Journal of Medicine. Certolizumab pegol blocks tumor necrosis factor, an important cause of inflammation in Crohn's disease
   Similar news · Read more »
   
2. Mayo Clinic study predicts cardiovascular disease risk for rheumatoid arthritis patients
   11-07-2007 · EurekAlert!
   People with rheumatoid arthritis have a higher risk for developing heart disease than the general population; however, it is difficult to identify which patients are at increased risk. Researchers at Mayo Clinic have developed a simple approach to predict heart disease in these patients within 10 years of their initial diagnosis of rheumatoid arthritis.
   Similar news · Read more »
   
3. Lupus gene finding prompts call for more DNA samples
   12-02-2007 · EurekAlert!
   Wellcome Trust researchers have identified a key gene involved in the disease lupus, which affects around 50,000 people in the UK, mostly women. The lead researcher behind the study has called for more patients to volunteer DNA samples to enable them to further study the underlying causes of the disease.
   Similar news · Read more »
   
4. UCSD researchers identify critical receptor in liver regeneration
   03-29-2007 · EurekAlert!
   In studies in mouse models, researchers at the University of California, San Diego (UCSD) School of Medicine have found that a cellular receptor involved in triggering cell death is also a necessary component of tissue repair and regeneration immediately following liver injury. This discovery could have implications for early intervention or therapy in liver disease such as cirrhosis or hepatitis.
   Similar news · Read more »
   
5. Patient adherence for successful tuberculosis treatment
   03-27-2007 · EurekAlert!
   Existing treatment against Tuberculosis is effective but long and many patients abandon it before the end or take their doses at excessively long intervals. In order to improve patients' adherence to treatment, IRD researchers are putting the emphasis on adaptation of control strategies to patients' real geographical, social, health and cultural situation. Trials conducted in Senegal showed the effectiveness of such an approach, which should limit the spread of the disease and the emergence of new resistant strains.
   Similar news · Read more »
   
6. Pancreatic cancer vaccine halts progression of disease in some patients
   04-17-2007 · EurekAlert!
   A dendritic cell-based therapeutic vaccine for pancreatic cancer developed by researchers at the University of Pittsburgh School of Medicine has successfully stalled the disease from progressing in a handful of patients three years post-vaccination. The results, part of a press briefing on cancer vaccines held at the annual meeting of the American Association of Cancer Research, provide promising evidence that the vaccine can trigger a patient's own immune system to rally against pancreatic cancer.
   Similar news · Read more »
   
7. BMI criteria for obesity surgery should be lowered, UT Southwestern researcher suggests
   12-18-2007 · EurekAlert!
   UT Southwestern Medical Center researchers have found that the existing body mass index criteria for obesity surgery often excludes a group of obese patients at risk of cardiovascular disease.
   Similar news · Read more »
   
8. OHSU surgeon gives patients with lethal cancer reason to hope
   11-30-2006 · EurekAlert!
   Researchers in the OHSU Digestive Health Center are developing a system through which clinicians hope to more easily identify people at increased risk for the disease. Early identification allows physicians to identify malignancies sooner and begin aggressive treatment quicker. Only patients at high risk for pancreatic cancer will be monitored.
   Similar news · Read more »
   
9. Positioning pelvic cancer patients on stomachs for radiation yields better results
   10-28-2007 · EurekAlert!
   Oregon Health & Science University Cancer Institute researchers have found that positioning pelvic cancer patients on their stomachs rather than their backs is a better method for delivering radiation therapy. Because patients return for multiple therapies, being able to reproduce the positioning of the patient allowed more precision, which reduces toxicity. "It was a surprising finding," according to according to Martin Fuss, M.D., the director of the Program in Image-Guided Radiation Therapy, OHSU Radiation Medicine.
   Similar news · Read more »
   
10. UCLA researchers discover biomarkers that predict lung cancer patient response to therapy
    01-31-2008 · EurekAlert!
    Researchers at UCLA's Jonsson Cancer Center have discovered biomarkers that predict which patients with advanced non-small cell lung cancer will respond to a combination treatment of the anti-inflammatory drug Celebrex and the growth factor receptor blocker Tarceva.
    Similar news · Read more »